We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$606M
AUM Growth
-$147M
(-20%)
Cap. Flow
-$17.7M
Cap. Flow
% of AUM
-2.92%
Top 10 Holdings %
Top 10 Hldgs %
26.18%
Holding
657
New
70
Increased
165
Reduced
211
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$24.8M |
| 2 |
Constellation Brands
STZ
|
+$12.7M |
| 3 |
HCA Healthcare
HCA
|
+$12.2M |
| 4 |
Avery Dennison
AVY
|
+$12M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$15.3M |
| 2 |
Masco
MAS
|
+$14.6M |
| 3 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$14.6M |
| 4 |
Cintas
CTAS
|
+$14.5M |
| 5 |
United Parcel Service
UPS
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.05% |
| 2 | Consumer Staples | 16.62% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Financials | 10.34% |
| 5 | Communication Services | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Merck
MRK
$355B
| $511K | 0.08% |
9,304
-796
| -8% | -$42.4K |
|
127
Starbucks
SBUX
$111B
| $509K | 0.08% |
8,905
+531
| +6% | +$30.2K |
|
128
Target
TGT
$70.7B
| $506K | 0.08% |
7,254
-166,742
| -96% | -$12.4M |
|
129
Transocean
RIG
$6.54B
| $493K | 0.08% |
41,496
-948,711
| -96% | -$9.7M |
|
|
AMAG
130
DELISTED
AMAG Pharmaceuticals
AMAG
| $470K | 0.08% |
19,663
+272
| +1% | +$6.24K |
|
|
LTM
131
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $460K | 0.08% |
69,772
+21,689
| +45% | +$143K |
|
132
Visa
V
$701B
| $453K | 0.07% |
6,106
-3,264
| -35% | -$256K |
|
133
Alcoa
AA
$12.2B
| $446K | 0.07% |
20,033
+6,700
| +50% | +$157K |
|
134
NNN REIT
NNN
$8.3B
| $444K | 0.07% |
8,587
+7,368
| +604% | +$342K |
|
|
COR
135
DELISTED
Coresite Realty Corporation
COR
| $443K | 0.07% |
4,995
+4,303
| +622% | +$332K |
|
136
AbbVie
ABBV
$463B
| $442K | 0.07% |
7,140
-3,702
| -34% | -$226K |
|
137
Las Vegas Sands
LVS
$27.1B
| $441K | 0.07% |
10,133
-2,453
| -19% | -$115K |
|
138
Macerich
MAC
$6.37B
| $436K | 0.07% |
5,101
+4,998
| +4,852% | +$391K |
|
139
Tanger
SKT
$4.16B
| $435K | 0.07% |
+10,818
| New | +$394K |
|
140
Simon Property Group
SPG
$66.1B
| $433K | 0.07% |
1,996
+1,952
| +4,436% | +$398K |
|
|
CONE
141
DELISTED
CyrusOne Inc Common Stock
CONE
| $432K | 0.07% |
7,761
+6,665
| +608% | +$321K |
|
|
LTC
142
LTC Properties
LTC
$2.33B
| $425K | 0.07% |
+8,208
| New | +$391K |
|
|
DFT
143
DELISTED
DuPont Fabros Technology Inc.
DFT
| $423K | 0.07% |
8,888
+7,675
| +633% | +$330K |
|
144
Oracle
ORCL
$406B
| $419K | 0.07% |
10,228
+2,169
| +27% | +$86.6K |
|
|
TCO
145
DELISTED
Taubman Centers Inc.
TCO
| $409K | 0.07% |
+5,515
| New | +$388K |
|
|
AIV
146
Aimco
AIV
$333M
| $409K | 0.07% |
+69,551
| New | +$385K |
|
147
Kinder Morgan
KMI
$68.2B
| $405K | 0.07% |
21,620
+2,569
| +13% | +$45.8K |
|
148
Essex Property Trust
ESS
$17.7B
| $404K | 0.07% |
1,770
+1,769
| +176,900% | +$395K |
|
149
SITE Centers
SITC
$151M
| $401K | 0.07% |
+17,166
| New | +$388K |
|
150
Gaming and Leisure Properties
GLPI
$11.8B
| $400K | 0.07% |
11,605
+9,941
| +597% | +$330K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2016 Portfolio in Review
As of Q2 2016, Exane Derivatives held 657 positions worth $606M, down 20% from $753M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives's Q2 2016 filing shows 70 new, 165 increased, 211 reduced and 108 closed positions. Its largest new stake was UBS Group: 1,623,142 shares worth $20.8M. The largest sale was Applied Materials, an estimated $15.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Exane Derivatives's largest Q2 2016 buy was UBS Group: 1,623,142 shares worth $20.8M.
- Exane Derivatives added most to Constellation Brands in Q2 2016, an estimated $12.7M increase.
- Exane Derivatives's biggest Q2 2016 reduction was Applied Materials, cutting an estimated $15.3M.
- Exane Derivatives fully exited Masco in Q2 2016, selling an estimated $14.6M.
- Exane Derivatives's ten largest holdings make up 26% of its $606M portfolio in Q2 2016.
- Exane Derivatives opened 70 new positions and closed 108 in Q2 2016.
- Exane Derivatives's portfolio value fell 20% quarter-over-quarter to $606M.
Based on Exane Derivatives's 13F filing for Q2 2016, filed 3 Aug 2016.